Est. 2013. Cambridge Innovation Capital is the leading VC for University of Cambridge commercialisation. £600m AUM across 5 funds incl. Fund III (£250m) & Opportunity Fund (£100m). Portfolio: 38-40 active cos, 104+ total investments incl. CMR Surgical, Pragmatic Semiconductor, Riverlane, T-Therapeutics, Gyroscope Therapeutics, Bicycle Therapeutics. 12-yr track record with 10 exits & £3.2bn co-investment capital attracted. Team: Andrew Williamson (Managing Partner).
Investment Focus
Investment Thesis
Cambridge-based VC investing £1-20m in life sciences & deep tech spinouts from University of Cambridge. Focus: therapeutics, medtech, diagnostics, AI, semiconductors, quantum computing, genomics. Stage: Series A primary. Differentiator: privileged access to university IP/founders via preferred investor relationship; £100m Fund III commitment to Cambridge spinouts. AUM £600m across 5 funds. Avoids: non-Cambridge ecosystem companies.
Interested in connecting?
Visit their website or reach out directly.